ER/PR negative tumors associated with insurance status
During heart failure the body reacts to the production of the hormone aldosterone. Too much aldosterone can stiffen and damage the muscles of the heart. Dutch researcher Luc Roumen has optimised compounds that inhibit the production of this hormone and looked at their optimum dosage. The compounds were manufactured by the companies Schering-Plough and
Full Post: New therapy for heart failure
African-American women are at a higher risk for ER/PR negative breast cancer.
A new study, to be presented at the American Association for Cancer Research’s Seventh Annual International Conference on Frontiers in Cancer Prevention Research, found that race, socioeconomic characteristics and other tumor characteristics are all important predictors of having ER/PR negative breast cancer.
ER/PR negative breast cancer has a poorer prognosis than hormonally-responsive cancer because treatment options are more limited.
In statistical models adjusted only for age, the study found that women who are uninsured or insured through Medicaid were 1.5 times more likely to have ER/PR negative tumors. Women who resided in low education versus high education zip codes were 1.6 times more likely to be diagnosed with ER/PR negative tumors. These findings were attenuated after controlling for race and other tumor characteristics which are highly associated with ER/PR status.
The risk of ER/PR negative breast cancers for African-American women dropped from 2.26 to 1.85 after controlling for socioeconomic status, stage at diagnosis, tumor size and histologic type.
“Hopefully, these findings will make us more aware that this more severe type of breast cancer is hitting minority and medically underserved women hardest, and we need to work toward finding prevention and therapeutic strategies,” said Elizabeth Ward, Ph.D., director of cancer surveillance research at the American Cancer Society.
Ward and colleagues studied the relationship between race, socioeconomics and breast cancer using the National Cancer Database, which collects data for approximately 1,500 cancer hospitals, representing 70 percent of cancer patients in the United States.
After excluding those women with missing information on ER/PR status, researchers were left with 175,820 women who were diagnosed with breast cancer.
“It appears that multiple factors contribute to the risk for ER/PR negative breast cancer. Some of these risk factors appear to be more common in poor and African-American women,” Ward said.
Obesity continues to increase for women in the United States, particularly among African-American and Mexican-American women. Between the ages of 35-44, there are approximately 3.3 million white women, 1.4 million African-American women, and 575,000 Mexican-American women who are obese. A new study published in the journal Public Health Nursing reveals that there is an increased
Full Post: Economic status affects obesity rates in Mexican-American and white women
Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center. The findings, presented today
Full Post: Early-stage breast cancer patients with HER2 positive tumors at increased risk of recurrence
Bladder cancer is much more likely to be deadly for women and African-Americans, but the reasons long believed to explain the phenomenon account for only part of the differences for such patients compared to their white and male counterparts, according to results published in the Jan. 1 issue of the journal Cancer. The results present
Full Post: Statistical analysis of bladder cancer
Once-promising drugs that were abandoned in the fight against breast cancer still could be effective in obese patients, new research suggests. In laboratory tests, hormones produced by fat cells stimulate breast cancer cells to migrate and invade surrounding tissues, scientists at Emory University School of Medicine found. A class of drugs called epithelial growth factor
Full Post: EGFR inhibitors show promise for obesity
A type of benign breast disease (BBD) known as atypical hyperplasia substantially increases a young woman’s risk of developing breast cancer, even if there is no history of breast cancer in her family, say researchers at Mayo Clinic. The investigators, who presented their findings at the Cancer Therapy & Research Center-American Association for Cancer Research
Full Post: Atypical hyperplasia increases risk of developing breast cancer